Clinical trial
A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its…
NCT00191828 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191828 |
|---|---|
| Title | A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme |
| Official title | A Prospective/Parallel Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Weight Gain |
| Intervention type | Drug |
| Interventions | olanzapine |
| Enrollment | 60 |
| Start date | Mar 1, 2003 |
| Completion | Aug 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: